BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Nuwarda RF, Alharbi AA, Kayser V. An Overview of Influenza Viruses and Vaccines. Vaccines (Basel) 2021;9:1032. [PMID: 34579269 DOI: 10.3390/vaccines9091032] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 16.0] [Reference Citation Analysis]
Number Citing Articles
1 Liang Y, Liu X, Hu J, Huang S, Ma X, Liu X, Wang R, Hu X. The crude extract from the flowers of Trollius chinensis Bunge exerts anti-influenza virus effects through modulation of the TLR3 signaling pathway. Journal of Ethnopharmacology 2023;300:115743. [DOI: 10.1016/j.jep.2022.115743] [Reference Citation Analysis]
2 Skupnevskii SV, Pukhaeva EG, Badtiev AK, Rurua FK, Batagova FE, Farnieva ZG. Improving safety of oil adjuvant-based vaccines. Russian Journal of Infection and Immunity 2022;12:953-962. [DOI: 10.15789/2220-7619-iso-1897] [Reference Citation Analysis]
3 Li L, Shi N, Xu N, Wang H, Zhao H, Xu H, Liu D, Zhang Z, Li S, Zhang J, Guo C, Huo J, Zhao M, Luo F, Yang L, Bai Y, Lu Q, Zhang Y, Zhong Y, Gao W. Safety and Viral Shedding of Live Attenuated Influenza Vaccine (LAIV) in Chinese Healthy Juveniles and Adults: A Phase Ⅰ Randomized, Double-Blind, Placebo-Controlled Study. Vaccines 2022;10:1796. [DOI: 10.3390/vaccines10111796] [Reference Citation Analysis]
4 Ramos-martínez IE, Ramos-martínez E, Segura-velázquez RÁ, Saavedra-montañez M, Cervantes-torres JB, Cerbón M, Papy-garcia D, Zenteno E, Sánchez-betancourt JI. Heparan Sulfate and Sialic Acid in Viral Attachment: Two Sides of the Same Coin? IJMS 2022;23:9842. [DOI: 10.3390/ijms23179842] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
5 Choi MJ, Yun J, Song JY, Ko K, Mould JF, Cheong HJ. A Comparative Analysis of Influenza-Associated Disease Burden with Different Influenza Vaccination Strategies for the Elderly Population in South Korea. Vaccines 2022;10:1387. [DOI: 10.3390/vaccines10091387] [Reference Citation Analysis]
6 Biselli R, Nisini R, Lista F, Autore A, Lastilla M, De Lorenzo G, Peragallo MS, Stroffolini T, D’amelio R. A Historical Review of Military Medical Strategies for Fighting Infectious Diseases: From Battlefields to Global Health. Biomedicines 2022;10:2050. [DOI: 10.3390/biomedicines10082050] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Chen H, Wang J, Liu Y, Ling IQE, Shih CC, Wu D, Fu Z, Lee RTC, Xu M, Chow VT, Maurer-stroh S, Zhou D, Liu J, Zhai W. MADE: A Computational Tool for Predicting Vaccine Effectiveness for the Influenza A(H3N2) Virus Adapted to Embryonated Eggs. Vaccines 2022;10:907. [DOI: 10.3390/vaccines10060907] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
8 Hensen L, Illing PT, Rowntree LC, Davies J, Miller A, Tong SYC, Habel JR, van de Sandt CE, Flanagan K, Purcell AW, Kedzierska K, Clemens EB. T Cell Epitope Discovery in the Context of Distinct and Unique Indigenous HLA Profiles. Front Immunol 2022;13:812393. [DOI: 10.3389/fimmu.2022.812393] [Reference Citation Analysis]
9 Rockman S, Taylor B, Mccauley JW, Barr IG, Longstaff R, Bahra R. Global Pandemic Preparedness: Optimizing Our Capabilities and the Influenza Experience. Vaccines 2022;10:589. [DOI: 10.3390/vaccines10040589] [Reference Citation Analysis]
10 Obermeier PE, Seeber LD, Alchikh M, Schweiger B, Rath BA. Incidence, Disease Severity, and Follow-Up of Influenza A/A, A/B, and B/B Virus Dual Infections in Children: A Hospital-Based Digital Surveillance Program. Viruses 2022;14:603. [DOI: 10.3390/v14030603] [Reference Citation Analysis]
11 Huang J, Ding Y, Yao J, Zhang M, Zhang Y, Xie Z, Zuo J. Nasal Nanovaccines for SARS-CoV-2 to Address COVID-19. Vaccines 2022;10:405. [DOI: 10.3390/vaccines10030405] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
12 Lee MH, Kim BJ. COVID-19 vaccine development based on recombinant viral and bacterial vector systems: combinatorial effect of adaptive and trained immunity. J Microbiol 2022;60:321-34. [PMID: 35157221 DOI: 10.1007/s12275-022-1621-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
13 Muchtaridi M, Nuwarda RF, Ikram EHK, Abdul Rahim AS, Gazzali AM, Wahab HA. Neuraminidase Inhibitor of Garcinia atroviridis L. Fruits and Leaves Using Partial Purification and Molecular Characterization. Molecules 2022;27:949. [DOI: 10.3390/molecules27030949] [Reference Citation Analysis]
14 Fernández Romero JA, Paglini MG, Priano C, Koroch A, Rodríguez Y, Sailer J, Teleshova N. Algal and Cyanobacterial Lectins and Their Antimicrobial Properties. Mar Drugs 2021;19:687. [PMID: 34940686 DOI: 10.3390/md19120687] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
15 Sullivan E, Sung P, Wu W, Berry N, Kempster S, Ferguson D, Almond N, Jones IM, Roy P. SARS-CoV-2 Virus like Particles produced by a single recombinant baculovirus generate potent neutralizing antibody that protects against variant challenge.. [DOI: 10.1101/2021.11.29.470349] [Reference Citation Analysis]